WILSONVILLE, Ore., April 6, 2018 /PRNewswire-iReach/ -- RevMedx, Inc., a leader in innovative devices that control severe
XSTAT devices work by injecting a group of small, rapidly-expanding sponges into a wound cavity using a syringe-like applicator. In a wound, the sponges rapidly expand and exert hemostatic pressure. Since its receiving initial FDA-clearance in the United States in 2014, there have been numerous successful uses of XSTAT devices in civilian and military pre-hospital settings.
Andrew Barofsky, President and CEO of RevMedx, Inc., stated, "CE Mark opens the opportunity for RevMedx to get our devices in the hands of emergency responders and surgeons in the European Union and around the world. This certification clearly indicates that the XSTAT devices and our supporting quality system met the essential requirements for product safety, performance and usability, in compliance with rigorous requirements set by the EU's Medical Device Directive (MDD)."
For victims of violence or accidents, early control of severe bleeding may prevent shock and may be life-saving. The United States Army Institute of Surgical Research reports that 30 to 40 percent of civilian deaths by traumatic injury are the result of hemorrhaging; of those deaths, 33 to 56 percent occur before the patient reaches an emergency care facility.
Based in Wilsonville, Oregon, RevMedx is a privately held medical device company whose goal is to design, develop, and manufacture innovative medical products that save lives. Our product line includes XSTAT, XGAUZE, AIRWRAP, PARABELT, SHARKBITE Blast Injury Kits, and TX Series Ratcheting Tourniquets. Additional information about RevMedx and our products can be found at www.revmedx.com.
VP Sales & Marketing
Phone: (503) 218-2172
Media Contact: Will Fox, RevMedx, Inc., 503-504-2642, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE RevMedx, Inc.
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All